Overall rank by patents
#35,300
of 49,997 tracked assignees
USPTO PatentsView assignee record - 7 granted patents across 5 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).
The verdict
According to USPTO PatentsView, Feldan ranks #35,300 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 5 technology areas.
USPTO PatentsView assignee plate
Corpus R35300 · Foreign Corporation #35,300 · 7 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
Nearest grant-volume peer: Fdn. For Res. & Bus., Seoul Nat. Univ. Of Sci. & Tech. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Feldan Bio · this assignee
41 score
Florida Institute… · near
41 score
Orckit IP · near
41 score
Pennsy · near
41 score
Shanghai XIN QI… · near
41 score
3D Lighting… · lowest
7 score
What this shows Feldan's Innovation Score is 41.0/100 (top 34% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Feldan Bio Inc. is a focused PatentsView assignee: 5 CPC subclasses with 100% of grants classified under C07K (Peptides). By volume, Feldan sits between Fdn. For Res. & Bus., Seoul Nat. Univ. Of Sci. & Tech. and Fibralign Corporation.
Feldan Bio Inc. shows 2 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Fdn. For Res. & Bus., Seoul Nat. Univ. Of Sci. & Tech.
7 patents
FedEx Corporation
7 patents
Federal State Budgetary Institution<Federal Agency for Legal Protection of Military, Special and Dual Use Intellectual Activity Results>(FSBI<FALPIAR>)
7 patents
Federal-Mogul Sealing Systems GmbH
7 patents
Fennec Pharmaceuticals, Inc.
7 patents
Fetch Rewards, LLC
7 patents
FiGPiN Collect Awesome, Inc.
7 patents
Fibralign Corporation
7 patents
Feldan Bio Inc.
7 patents
What this shows Feldan holds 7 patents at rank #35,351, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #35,351 in granted patent volume.
Other assignees with the most granted patents in Feldan's primary technology class.
Two PlainPatent-derived peer sets for Feldan, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (41 here).
Feldan's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
41 Top 34% higher than 66% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 1 | 14.3% |
| 2018 | 1 | 14.3% |
| 2020 | 1 | 14.3% |
| 2023 | 1 | 14.3% |
| 2024 | 1 | 14.3% |
| 2025partial year | 2 | 28.6% |
Top 5 of 5 technology areas
Overall rank by patents
#35,300
of 49,997 tracked assignees
41.0 out of 100
What to do with this data
Feldan Bio Inc.'s patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.